Medical Device & IVD Regulation Audit Services

Medical device and IVD regulation audit services are structured reviews of your quality system, technical documentation, risk management records, labeling, and post-market processes against applicable standards such as FDA requirements, ISO 13485, EU MDR, IVDR, and MDSAP. The goal is to identify compliance gaps before an external audit or inspection, prioritize remediation, and improve your organization's readiness to respond confidently to auditors and regulators.

An internal regulatory audit helps uncover weaknesses before they become formal observations during an FDA inspection, notified body audit, or certification review. It gives your team time to correct documentation gaps, incomplete traceability, weak procedures, overdue records, or inconsistent implementation. A well-run internal audit also improves staff preparedness, strengthens evidence quality, and reduces the risk of delays, nonconformities, or repeated follow-up actions.

Elexes supports audits and readiness assessments against a wide range of frameworks, including FDA quality system requirements, ISO 13485, ISO 14971, EU MDR, EU IVDR, MDSAP, GLP, GCP, IEC 62304, and related market-specific expectations. Audit scope can be tailored to a single standard or built around multiple jurisdictions when manufacturers need one coordinated review for global compliance planning.

A typical audit assessment includes review of your QMS procedures, design and development records, RMF and DHF documentation, technical files, complaint handling, CAPA, PMS activities, labeling, training records, and submission-supporting evidence. Elexes also evaluates traceability, implementation consistency, and audit readiness. The output usually includes documented findings, severity-based gap prioritization, and a practical remediation plan with recommended next steps.

Yes. Many manufacturers need to align one quality system and documentation set across multiple markets. Elexes can assess overlapping and market-specific requirements for FDA, EU MDR, IVDR, TGA, Health Canada, and other frameworks in one coordinated engagement. This helps reduce duplicated effort, identify conflicting documentation assumptions, and create a more efficient remediation roadmap for global submissions, audits, and ongoing compliance.

Elexes does more than identify gaps. After the audit, the team can help prioritize findings by regulatory risk, clarify root causes, and support remediation across procedures, technical documentation, risk files, complaint systems, and quality records. This may include authoring or revising documents, improving traceability, preparing CAPA responses, and aligning evidence to the exact regulatory expectations that external auditors or reviewers are likely to apply.

Audit services are valuable for startups preparing for first submissions, scaling manufacturers facing certification or surveillance audits, and established companies managing complex global portfolios. They are especially useful before FDA inspections, notified body reviews, ISO 13485 certification audits, MDSAP audits, major submissions, design changes, or market expansions. IVD manufacturers, SaMD developers, and clinical diagnostics organizations also benefit from targeted readiness reviews.

Most manufacturers should perform internal audits at planned intervals throughout the year, with frequency based on risk, product complexity, regulatory exposure, and recent quality events. High-risk processes such as CAPA, complaint handling, design controls, supplier controls, and PMS may need more frequent review. Additional audits are also advisable before major submissions, certification audits, remediation closeout, or after significant organizational or product changes.